title: IgA nephropathy with crescents in kidney transplant recipients.
abstract: BACKGROUND
  Crescentic glomerulonephritis is an uncommon finding in renal allografts. Recurrence or de novo mesangial deposition of immunoglobulin A (IgA) in renal allografts most often is clinically benign, but some case reports have shown that IgA nephropathy in renal allografts can present as crescentic glomerulonephritis and may lead to rapid deterioration of graft function and/or graft loss.
  
  
  METHODS
  We reviewed diagnoses of all allograft biopsies at University of Washington Medical Center (Seattle, WA) from 1989 to 2003 and found 33 cases of glomerulonephritis with crescents. Eight of these cases were the result of recurrent or de novo IgA nephropathy. Clinical and pathological features of these patients were reviewed.
  
  
  RESULTS
  Six of 8 cases with crescents were the result of recurrent IgA nephropathy, and 2 cases were presumptive de novo IgA nephropathy. Of the 8 patients with IgA nephropathy with crescents, 6 patients presented clinically with increasing serum creatinine levels; 4 patients, with proteinuria; and 4 patients, with hematuria. In 6 patients, there was 10% to 30% involvement of glomeruli, with crescents partially or completely filling urinary spaces. The other patients showed lesser (approximately 7% of sampled glomeruli) involvement. Four patients with IgA nephropathy with crescents developed renal failure and returned to hemodialysis therapy. Three patients had a benign clinical course, with stabilization of renal function. One patient was lost to follow-up.
  
  
  CONCLUSIONS
  We identified a cohort of patients with glomerulonephritis with crescents in renal allografts with IgA nephropathy as the cause. In half the affected patients, this led to early progressive renal insufficiency and return to hemodialysis therapy.
authors.affiliation: Department of Pathology, University of Washington, Seattle, WA, USA. jkowal@u.washington.edu
authors.forename: Jolanta
authors.initials: J
authors.lastname: Kowalewska
authors.forename: Shan
authors.initials: S
authors.lastname: Yuan
authors.forename: Neodjema
authors.initials: N
authors.lastname: Sustento-Reodica
authors.forename: Roberto F
authors.initials: RF
authors.lastname: Nicosia
authors.forename: Kelly D
authors.initials: KD
authors.lastname: Smith
authors.forename: Connie L
authors.initials: CL
authors.lastname: Davis
authors.forename: Charles E
authors.initials: CE
authors.lastname: Alpers
mesh_terms: D000328:Adult; D005260:Female; D005922:Glomerulonephritis, IGA / Q000188:drug therapy / Q000473:pathology*; D005923:Glomerulosclerosis, Focal Segmental / Q000188:drug therapy / Q000473:pathology; D006084:Graft Rejection / Q000150:complications / Q000188:drug therapy; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D007676:Kidney Failure, Chronic / Q000209:etiology / Q000628:therapy; D007678:Kidney Glomerulus / Q000473:pathology / Q000648:ultrastructure; D016030:Kidney Transplantation / Q000009:adverse effects*; D008297:Male; D008854:Microscopy, Electron / Q000379:methods; D008856:Microscopy, Fluorescence / Q000379:methods; D008875:Middle Aged; D006435:Renal Dialysis / Q000379:methods